↓ Skip to main content

A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune Cells

Overview of attention for article published in Frontiers in oncology, May 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
8 Mendeley